Literature DB >> 18757368

In vivo analysis of protein kinase B (PKB)/Akt regulation in DNA-PKcs-null mice reveals a role for PKB/Akt in DNA damage response and tumorigenesis.

Banu Surucu1, Lana Bozulic, Debby Hynx, Arnaud Parcellier, Brian A Hemmings.   

Abstract

Full activation of protein kinase B (PKB/Akt) requires phosphorylation on Thr-308 and Ser-473. It is well established that Thr-308 is phosphorylated by 3-phosphoinositide-dependent kinase-1 (PDK1). Ser-473 phosphorylation is mediated by both mammalian target of rapamycin-rictor complex (mTORC2) and DNA-dependent protein kinase (DNA-PK) depending on type of stimulus. However, the physiological role of DNA-PK in the regulation of PKB phosphorylation remains to be established. To address this, we analyzed basal, insulin-induced, and DNA damage-induced PKB Ser-473 phosphorylation in DNA-PK catalytic subunit-null DNA-PKcs(-/-) mice. Our results revealed that DNA-PK is required for DNA damage-induced phosphorylation but dispensable for insulin- and growth factor-induced PKB Ser-473 phosphorylation. Moreover, DNA-PKcs(-/-) mice showed a tissue-specific increase in basal PKB phosphorylation. In particular, persistent PKB hyperactivity in the thymus apparently contributed to spontaneous lymphomagenesis in DNA-PKcs(-/-) mice. Significantly, these tumors could be prevented by deletion of PKBalpha. These findings reveal stimulus-specific regulation of PKB activation by specific upstream kinases and provide genetic evidence of PKB deregulation in DNA-PKcs(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18757368      PMCID: PMC2662067          DOI: 10.1074/jbc.M803053200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia.

Authors:  Steven M Chan; Andrew P Weng; Robert Tibshirani; Jon C Aster; Paul J Utz
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

Review 2.  Stressing the role of FoxO proteins in lifespan and disease.

Authors:  Armando van der Horst; Boudewijn M T Burgering
Journal:  Nat Rev Mol Cell Biol       Date:  2007-06       Impact factor: 94.444

Review 3.  PKB and the mitochondria: AKTing on apoptosis.

Authors:  Arnaud Parcellier; Lionel A Tintignac; Elena Zhuravleva; Brian A Hemmings
Journal:  Cell Signal       Date:  2007-07-25       Impact factor: 4.315

4.  Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.

Authors:  Teresa Palomero; Maria Luisa Sulis; Maria Cortina; Pedro J Real; Kelly Barnes; Maria Ciofani; Esther Caparros; Jean Buteau; Kristy Brown; Sherrie L Perkins; Govind Bhagat; Archana M Agarwal; Giuseppe Basso; Mireia Castillo; Satoru Nagase; Carlos Cordon-Cardo; Ramon Parsons; Juan Carlos Zúñiga-Pflücker; Maria Dominguez; Adolfo A Ferrando
Journal:  Nat Med       Date:  2007-09-16       Impact factor: 53.440

5.  FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.

Authors:  Caroline Bouchard; Soyoung Lee; Viola Paulus-Hock; Christoph Loddenkemper; Martin Eilers; Clemens A Schmitt
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

6.  Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition.

Authors:  Changchuin Mao; Esmerina G Tili; Marei Dose; Mariëlle C Haks; Susan E Bear; Ioanna Maroulakou; Kyoji Horie; George A Gaitanaris; Vincenzo Fidanza; Thomas Ludwig; David L Wiest; Fotini Gounari; Philip N Tsichlis
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

7.  Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation.

Authors:  Marisa M Juntilla; Jessica A Wofford; Morris J Birnbaum; Jeffrey C Rathmell; Gary A Koretzky
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

8.  Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death.

Authors:  Hong-Gang Yu; Yao-Wei Ai; Liang-Liang Yu; Xiao-Dong Zhou; Jin Liu; Jun-Hua Li; Xi-Ming Xu; Song Liu; Jing Chen; Fen Liu; Yuan-Ling Qi; Quanjun Deng; Jun Cao; Shi-Quan Liu; He-Sheng Luo; Jie-Ping Yu
Journal:  Int J Cancer       Date:  2008-01-15       Impact factor: 7.396

Review 9.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  Deletion of PKBalpha/Akt1 affects thymic development.

Authors:  Elisabeth Fayard; Jason Gill; Magdalena Paolino; Debby Hynx; Georg A Holländer; Brian A Hemmings
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

View more
  30 in total

Review 1.  PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

Review 2.  mTOR complex 2 signaling and functions.

Authors:  Won Jun Oh; Estela Jacinto
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

3.  Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors.

Authors:  Theresa D Carr; Robert P Feehan; Michael N Hall; Markus A Rüegg; Lisa M Shantz
Journal:  Carcinogenesis       Date:  2015-03-04       Impact factor: 4.944

4.  DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.

Authors:  Euan A Stronach; Michelle Chen; Elaina N Maginn; Roshan Agarwal; Gordon B Mills; Harpreet Wasan; Hani Gabra
Journal:  Neoplasia       Date:  2011-11       Impact factor: 5.715

5.  Repair of radiation damage of U2OS osteosarcoma cells is related to DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity.

Authors:  Xianye Tang; Feng Yuan; Kaijin Guo
Journal:  Mol Cell Biochem       Date:  2014-01-05       Impact factor: 3.396

Review 6.  Role of AKT signaling in DNA repair and clinical response to cancer therapy.

Authors:  Qun Liu; Kristen M Turner; W K Alfred Yung; Kexin Chen; Wei Zhang
Journal:  Neuro Oncol       Date:  2014-05-07       Impact factor: 12.300

7.  Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation.

Authors:  Yikun Li; Xuerong Wang; Ping Yue; Hui Tao; Suresh S Ramalingam; Taofeek K Owonikoko; Xingming Deng; Ya Wang; Haian Fu; Fadlo R Khuri; Shi-Yong Sun
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

8.  Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

Authors:  Nishant Gandhi; Aaron T Wild; Sivarajan T Chettiar; Khaled Aziz; Yoshinori Kato; Rajendra P Gajula; Russell D Williams; Jessica A Cades; Anvesh Annadanam; Danny Song; Yonggang Zhang; Russell K Hales; Joseph M Herman; Elwood Armour; Theodore L DeWeese; Edward M Schaeffer; Phuoc T Tran
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

Review 9.  The role of DNA-PK in aging and energy metabolism.

Authors:  Jay H Chung
Journal:  FEBS J       Date:  2018-03-12       Impact factor: 5.542

10.  Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice.

Authors:  Eddy S Yang; Hong Wang; Guochun Jiang; Somaira Nowsheen; Allie Fu; Dennis E Hallahan; Fen Xia
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.